Molecular Imaging: Page 46

PET reveals brain effects of nicotine in women

By Will Morton

PET imaging has revealed for the first time that nicotine appears to block a brain enzyme in women involved in estrogen production, according to a study published March 5 in Comprehensive Psychiatry.

March 6, 2023

GE HealthCare offers experiences, upgrades at ECR 2023

By Erik L. Ridley and Frances Rylands-Monk

VIENNA - GE HealthCare showcased a range of new imaging hardware and software, as well as new "immersive experiences" in its first time participating in an ECR as an independent public traded company.

March 4, 2023

Turn it off! Idle machines are wasting energy, study finds

By Will Morton

Radiology departments can help prevent climate change by turning off idle imaging scanners and workstations during off hours, according to a March 2 presentation at ECR 2023 in Vienna.

March 3, 2023

PEM shows promise in study presented at ECR

By Amerigo Allegretto

Positron emission mammography (PEM) allows for more accurate evaluation of breast cancer's response to chemotherapy, as well as residual tissue, according to findings presented March 2 at ECR 2023.

March 2, 2023

FDG-PET/CT reveals sites of COVID-19 brain infection

By Will Morton

FDG-PET/CT imaging shows metabolic neurologic changes due to COVID-19 in patients before the onset of anatomical abnormalities and can detect more active infection sites than MRI, according to research presented March 2 at ECR 2023 in Vienna.

March 2, 2023

FAPI-PET shows promise in patients with RA

By Will Morton

FAPI-PET can visualize changes in the joints of patients with rheumatoid arthritis (RA) and appears promising as a tool for monitoring patients undergoing treatment, according to a study published February 28 in Radiology.

March 1, 2023

ECR: PSMA-RADS 1.0 validated in prostate cancer patients

By Will Morton

Researchers in Germany have validated a system called PSMA-RADS 1.0 for clinicians to interpret PET/CT scans in patients with prostate cancer, according to a presentation March 1 at ECR 2023 in Vienna.

March 1, 2023

GE HealthCare completes recruitment for contrast development

By AuntMinnie.com staff writers

GE HealthCare has announced the completion of phase I subject recruitment for the development of a first-of-its-kind manganese-based macrocyclic MRI contrast agent.

February 28, 2023

Immuno-PET predicts patient response to rituximab therapy

By Will Morton

Zirconium-89 rituximab PET imaging shows promise for identifying whether patients with autoimmune lung disease may respond to immunotherapy treatment, according to a group in the Netherlands.

February 27, 2023

PET AI model improves lung cancer staging

By Will Morton

An artificial intelligence (AI) model based on routine data from F-18 FDG-PET/CT scans can improve accuracy when staging treatment for patients with metastatic lung cancer, according to a group in Germany.

February 26, 2023

GE HealthCare close to completing safety recall

By Amerigo Allegretto

GE HealthCare has nearly completed its previously announced safety recall of the company's 600 and 800 series nuclear medicine systems.

February 23, 2023

SNMMI issues new guideline for PET imaging of neuroendocrine tumors

By Will Morton

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine have released a new practice guideline for somatostatin receptor PET imaging of patients with neuroendocrine tumors.

February 23, 2023

Previous Page

Page 46 of 612

Next Page